A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)
Clinical trial NCT07229625 · RECRUITING
Trial details
- NCT number
- NCT07229625
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-21
- Primary completion
- 2029-12-01
- Enrollment
- 604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.